VALIANTLABBSEValiant Laboratories LtdMinimalNeutral
Announced Sat, 16 May · 14:04 IST

Copy of Newspaper Publication of Financial Results for the quarter and year ended 31 March, 2026.

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.1%1-day move
₹79.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.1-4.6-4.4-2.2-1.4+1.3-7.6-12.7-18.9
Up moveDown movePending
AI summary

Valiant Laboratories Ltd has published its audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026. The company showed a significant turnaround, reporting net profit of approximately Rs. 554.82 lakh for FY26 compared to a net loss of Rs. 326.79 lakh in the previous year. Total income for the year stood at approximately Rs. 5,842.39 lakh. Q4FY26 also showed positive performance with net profit of Rs. 70.36 lakh versus a loss of Rs. 22.12 lakh in Q4FY25. Earnings per share improved from negative Rs. 0.51 in FY25 to Rs. 1.02 in FY26. The results were published in Financial Express and Mumbai Lakshadeep on May 16, 2026, in compliance with SEBI LODR regulations.

Likely market impact

The company has demonstrated a strong recovery from losses to profitability, which is a positive signal for shareholders. The turnaround in earnings per share from negative to positive territory indicates improved operational performance and financial health.